The DOI matches its Crossref record; 74 of the 76 references it cites were found in a registry or an index.
Eicosapentaenoic acid reduces membrane fluidity, inhibits cholesterol domain formation, and normalizes bilayer width in atherosclerotic-like model membranes
Open accessAbstract
Cholesterol crystalline domains characterize atherosclerotic membranes, altering vascular signaling and function. Omega-3 fatty acids reduce membrane lipid peroxidation and subsequent cholesterol domain formation. We evaluated non-peroxidation-mediated effects of eicosapentaenoic acid (EPA), other TG-lowering agents, docosahexaenoic acid (DHA), and other long-chain fatty acids on membrane fluidity, bilayer width, and cholesterol domain formation in model membranes. In membranes prepared at 1.5:1 cholesterol-to-phospholipid (C/P) mole ratio (creating pre-existing domains), EPA, glycyrrhizin, arachidonic acid, and alpha linolenic acid promoted the greatest reductions in cholesterol domains (by 65.5%, 54.9%, 46.8%, and 45.2%, respectively) compared to controls; other treatments had modest effects. EPA effects on cholesterol domain formation were dose-dependent. In membranes with 1:1 C/P (predisposing domain formation), DHA, but not EPA, dose-dependently increased membrane fluidity. DHA also induced cholesterol domain formation without affecting temperature-induced changes in-bilayer unit cell periodicity relative to controls (d-space; 57Å-55Å over 15-30°C). Together, these data suggest simultaneous formation of distinct cholesterol-rich ordered domains and cholesterol-poor disordered domains in the presence of DHA. By contrast, EPA had no effect on cholesterol domain formation and produced larger d-space values relative to controls (60Å-57Å; p<0.05) over the same temperature range, suggesting a more uniform maintenance of lipid dynamics despite the presence of cholesterol. These data indicate that EPA and DHA had different effects on membrane bilayer width, membrane fluidity, and cholesterol crystalline domain formation; suggesting omega-3 fatty acids with differing chain length or unsaturation may differentially influence membrane lipid dynamics and structural organization as a result of distinct phospholipid/sterol interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“a broad literature examining effects of EPA vs EPA/DHA at the molecular and cellular levels,39, 40, 41, 42 their effects at the level of atherosclerotic plaque quantifiable with clinical imaging,8 and their effects at the clinical endpoint level evidenced in the RCT literature reviewed here, all suggest more robust benefit with purified EPA rather than mixed EPA/DHA.”
From Effects of Eicosapentaenoic Acid vs Eicosapentaenoic/Docosahexaenoic Acids on Cardiovascular Mortality (2025) · cites this paper as [42]
In the citing paper
“Multiple epidemiological and genetic analyses have demonstrated an independent association with increased cardiovascular risk (14)”
From Effects of Icosapent Ethyl on Total Ischemic Events (2019) · cites this paper as [18]
In the citing paper
“EPA and DHA interact differently with cellular membranes”
From Cardiovascular Impact of Nutritional Supplementation With Omega-3 Fatty Acids (2021) · cites this paper as [27]
In the citing paper
“prevents lipid oxidation”
From Cardiovascular Impact of Nutritional Supplementation With Omega-3 Fatty Acids (2021) · cites this paper as [27]
In the citing paper
“compared with DHA, EPA has a more stable, extended structure”
From Cardiovascular Impact of Nutritional Supplementation With Omega-3 Fatty Acids (2021) · cites this paper as [27]
In the citing paper
“promotes membrane stability”
From Cardiovascular Impact of Nutritional Supplementation With Omega-3 Fatty Acids (2021) · cites this paper as [27]
In the citing paper
“inhibits inflammation”
From Cardiovascular Impact of Nutritional Supplementation With Omega-3 Fatty Acids (2021) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664
Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61239-8 · Cited by 1,350
Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014682.14181.f2 · Cited by 1,311
Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
Varbo, A., Benn, M., Tybjærg-Hansen, A., Jørgensen, A. B., Frikke-Schmidt, R., & Nordestgaard, B. G. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.1026 · Cited by 1,115
Rizos, E. C., Ntzani, E. E., Bika, E., Kostapanos, M. S., & Elisaf, M. S. (2012) · JAMA · doi:10.1001/2012.jama.11374 · Cited by 960
n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
Kromhout, D., Giltay, E. J., & Geleijnse, J. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003603 · Cited by 936
n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203859 · Cited by 929
Yan, Y., Jiang, W., Spinetti, T., Tardivel, A., Castillo, R., Bourquin, C., Guarda, G., Tian, Z., Tschopp, J., & Zhou, R. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.015 · Cited by 784
心筋梗塞後のn-3多価不飽和脂肪酸とビタミンEの食事補給:GISSI-Prevenzione試験の結果
Marchioli, R., Valagussa, F., Franzosi, M. G., Geraci, E., Mininni, N., Nicolosi, G. L., Santini, M., Tavazzi, L., & Vecchio, C. (1999) · The Lancet · Cited by 702
Varbo, A., Benn, M., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2013) · Circulation · doi:10.1161/circulationaha.113.003008 · Cited by 692
Rauch, B., Schiele, R., Schneider, S., Diller, F., Victor, N., Gohlke, H., Gottwik, M., Steinbeck, G., Del Castillo, U., Sack, R., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.948562 · Cited by 607
n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
The Risk and Prevention Study Collaborative Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205409 · Cited by 510
Galan, P., Kesse-Guyot, E., Czernichow, S., Briancon, S., Blacher, J., Hercberg, S., & for the SU.FOL.OM3 Collaborative Group (2010) · BMJ · doi:10.1136/bmj.c6273 · Cited by 457
Maximum solubility of cholesterol in phosphatidylcholine and phosphatidylethanolamine bilayers
Huang, J., Buboltz, J. T., & Feigenson, G. W. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00260-0 · Cited by 440
Small, D. M. (1988) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.8.2.103 · Cited by 391
Saito, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.06.003 · Cited by 316
Martínez, G. J., Robertson, S. E. J., Barraclough, J., Xia, Q., Mallat, Z., Bursill, C. A., Celermajer, D. S., & Patel, S. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002128 · Cited by 291
Varbo, A., Benn, M., & Nordestgaard, B. G. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.008 · Cited by 251
Role of caveolin and caveolae in insulin signaling and diabetes
Cohen, A. W., Combs, T. P., Scherer, P. E., & Lisanti, M. P. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00324.2003 · Cited by 222
Tanaka, K., Ishikawa, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Saito, Y., Matsuzawa, Y., Sasaki, J., Oikawa, S., Hishida, H., et al. (2008) · Stroke · doi:10.1161/strokeaha.107.509455 · Cited by 217
Yang, X., Sheng, W., Sun, G. Y., & Lee, J. C. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.12.004 · Cited by 215
Docosahexaenoic acid domains: the ultimate non-raft membrane domain
Wassall, S. R., & Stillwell, W. H. (2008) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2008.02.010 · Cited by 208
Liu, J., Zeng, F., Liu, Z., Zhang, C., Ling, W., & Chen, Y. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-159 · Cited by 197
Hashimoto, M., Hossain, M. S., Yamasaki, H., Yazawa, K., & Masumura, S. (1999) · Lipids · doi:10.1007/s11745-999-0481-6 · Cited by 189
Phospholipid/cholesterol model membranes: formation of cholesterol crystallites
Bach, D., & Wachtel, E. J. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(03)00017-8 · Cited by 181
Shaikh, S. R., Kinnun, J. J., Leng, X., Williams, J. A., & Wassall, S. R. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.04.020 · Cited by 179
Borow, K. M., Nelson, J. R., & Mason, R. P. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.07.035 · Cited by 175
Kim, W., Fan, Y., Barhoumi, R., Smith, R., McMurray, D. N., & Chapkin, R. S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6236 · Cited by 175
Residual macrovascular risk in 2013: what have we learned?
(R3i), F. T. R. R. R. I., Fruchart, J., Davignon, J., Hermans, M. P., Al-Rubeaan, K. A., Amarenco, P., Assmann, G., Barter, P. J., Betteridge, J. D., Bruckert, É., et al. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-26 · Cited by 174
Tulenko, T. N., Chen, M., Mason, P. E., & Mason, R. P. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33861-x · Cited by 172
Self-citationCrystallization of Free Cholesterol in Model Macrophage Foam Cells
Kellner-Weibel, G., Yancey, P. G., Jerome, W. G., Walser, T., Mason, R. P., Phillips, M. C., & Rothblat, G. H. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.8.1891 · Cited by 170
Self-citationDocosahexaenoic and eicosapentaenoic acids segregate differently between raft and nonraft domains
Williams, J. A., Batten, S. E., Harris, M., Rockett, B. D., Shaikh, S. R., Stillwell, W., & Wassall, S. R. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.06.016 · Cited by 168
Matsuzaki, M., Yokoyama, M., Saitō, Y., Origasa, H., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., Kita, T., et al. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-1197 · Cited by 157
Casula, M., Soranna, D., Catapano, A. L., & Corrao, G. (2013) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(13)70005-9 · Cited by 152
Lipid Peroxidation Induces Cholesterol Domain Formation in Model Membranes
Jacob, R. F., & Mason, R. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507587200 · Cited by 152
Self-citationBays, H. E., Ballantyne, C. M., Braeckman, R. A., Stirtan, W. G., & Soni, P. N. (2013) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-012-0002-3 · Cited by 141
Shaikh, S. R. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.07.001 · Cited by 134
Nishio, R., Shinke, T., Otake, H., Nakagawa, M., Nagoshi, R., Inoue, T., Kozuki, A., Hariki, H., Osue, T., Taniguchi, Y., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.02.025 · Cited by 133
Liu, X., Xue, Y., Liu, C., Lou, Q., Wang, J., Yanagita, T., Xue, C., & Wang, Y. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-109 · Cited by 128
Abela, G. S., & Aziz, K. S. (2006) · Scanning · doi:10.1002/sca.4950280101 · Cited by 123
Geleijnse, J. M., Giltay, E. J., Schouten, E. G., de Goede, J., Griep, L. M. O., Teitsma-Jansen, A., Katan, M., & Kromhout, D. (2010) · American Heart Journal · doi:10.1016/j.ahj.2009.12.033 · Cited by 112
Oxidative stress impairs insulin internalization in endothelial cells in vitro
Bertelsen, M. F., Änggård, E., & CARRIER, M. J. (2001) · Diabetologia · doi:10.1007/s001250051667 · Cited by 98
Chunyu, Z., Christina, K., Katsunori, I., & Sacks, F. M. (2007) · Journal of Lipid Research · doi:10.1194/jlr.p600011-jlr200 · Cited by 95
Herbette, L. G., DeFoor, P. H., Fleischer, S., Pascolini, D., Scarpa, A., & Blasie, J. K. (1985) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(85)90073-2 · Cited by 89
Mason, R. P., Walter, M. F., Day, C. A., & Jacob, R. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513000200 · Cited by 86
Self-citationMason, R. P., & Jacob, R. F. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.10.016 · Cited by 78
Self-citationRuocco, M. J., & Shipley, G. G. (1984) · Biophysical Journal · doi:10.1016/s0006-3495(84)84068-0 · Cited by 77
Usui, K., Hiraki, T., Kawamoto, J., Kurihara, T., Nogi, Y., Kato, C., & Abe, F. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.10.010 · Cited by 74
Mason, R. P., Sherratt, S. C. R., & Jacob, R. F. (2016) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000379 · Cited by 72
Self-citationWu, Y., Zhang, C., Dong, Y., Wang, S., Song, P., Viollet, B., & Zou, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035508 · Cited by 64
Membrane Microdomains and Vascular Biology
Mason, R. P., & Jacob, R. F. (2003) · Circulation · doi:10.1161/01.cir.0000062607.02451.b6 · Cited by 64
Self-citationShrivastava, S. K., Paila, Y. D., Dutta, A., & Chattopadhyay, A. (2008) · Biochemistry · doi:10.1021/bi8001677 · Cited by 61
Self-citationMason, R. P., Gonye, G. E., Chester, D. W., & Herbette, L. G. (1989) · Biophysical Journal · doi:10.1016/s0006-3495(89)82875-9 · Cited by 56
Self-citationBarrett, M. A., Zheng, S., Toppozini, L., Alsop, R. J., Dies, H., Wang, A., Jago, N. M., Moore, M., & Rheinstadter, M. C. (2013) · Soft Matter · doi:10.1039/c3sm50700a · Cited by 54
Docosahexaenoyl Chains Isomerize on the Sub-Nanosecond Time Scale
Soubias, O., & Gawrisch, K. (2007) · Journal of the American Chemical Society · doi:10.1021/ja068856c · Cited by 48
7-Ketocholesterol forms crystalline domains in model membranes and murine aortic smooth muscle cells
Phillips, J. E., Geng, Y., & Mason, R. P. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00504-4 · Cited by 44
Self-citationSakamoto, S., Nakahara, H., Uto, T., Shoyama, Y., & Shibata, O. (2013) · Biochimica et Biophysica Acta · doi:10.1016/j.bbamem.2013.01.006 · Cited by 42
Omega-3 polyunsaturated fatty acids and oxygenated metabolism in atherothrombosis
Guichardant, M., Calzada, C., Bernoud‐Hubac, N., Lagarde, M., & Véricel, E. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.09.013 · Cited by 42
Yamano, T., Kubo, T., Shiono, Y., Shimamura, K., Orii, M., Tanimoto, T., Matsuo, Y., Ino, Y., Kitabata, H., Yamaguchi, T., et al. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.25593 · Cited by 40
Kim, W., Barhoumi, R., McMurray, D. N., & Chapkin, R. S. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513002444 · Cited by 34
Sasaki, J., Miwa, T., & Odawara, M. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej11-0394 · Cited by 31
Garg, S., Castro-Román, F., Porcar, L., Butler, P. D., Bautista, P. J., Krzyzanowski, N., & Perez-Salas, U. A. (2014) · Soft Matter · doi:10.1039/c4sm01219d · Cited by 28
LU, L., Okada, N., Nakatani, S., & Yoshikawa, K. (1995) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1995.tb02618.x · Cited by 20
Ando, K., Watanabe, T., Daidoji, H., Otaki, Y., Hashimoto, N., Kumagai, Y., Hashimoto, N., Narumi, T., Kadowaki, S., Yamaura, G., et al. (2015) · Circulation · doi:10.1161/circ.132.suppl_3.12007 · Cited by 16
Shintani, Y., & Kawasaki, T. (2012) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(12)61732-x · Cited by 13
In vitro determination of the solubility limit of cholesterol in phospholipid bilayers
Epand, R. M., Bach, D., & Wachtel, E. J. (2016) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2016.06.006 · Cited by 11
Uehara, H., Miyagi, N., Shimajiri, M., & Nago, C. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht310.p5495 · Cited by 10
Allograft vasculopathy vs. coronary artery disease: comparison by optical coherence tomography
Templin, C., Ghadri, J. R., Noll, G., Lüscher, T. F., & Ruschitzka, F. T. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs303 · Cited by 9
Domei, T., Amemiya, K., Enomoto, S., Ichihashi, K., Yokoi, H., Iwabuchi, M., & Nobuyoshi, M. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht307.p689 · Cited by 8
Is There a Role for Colchicine in Acute Coronary Syndromes?
Nidorf, S. M., & Verma, S. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002372 · Cited by 8
Wakita, Y., Wakida, Y., Itou, T., & Mizuno, R. (2013) · Stroke · doi:10.1161/str.44.suppl_1.awp413 · Cited by 4
Flagged first, then by citations
2 of the 76 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Small, 1988, Progression and regression of atherosclerotic lesions. Insights from lipid physical biochemistry, Arterioscler. Thromb. Vasc. Biol., 8, 103
- Niki, 2012, Effects of additional eicosapentaenoic adic to statin therapy on inflammatory cytokines and the tissue characterization of coronary plaque assessed by integrated backscatter intravascular ultrasound systems [abstract 14434], Circulation, 126, 14434
Cited by
Sorted by citations
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317
Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid
Mason, R. P., Libby, P., & Bhatt, D. L. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.313286 · Cited by 407
Self-citationBailly, C., & Vergoten, G. (2020) · Pharmacology and Therapeutics · doi:10.1016/j.pharmthera.2020.107618 · Cited by 261
Dietary fatty acids fine-tune Piezo1 mechanical response
Romero, L. O., Massey, A. E., Mata‐Daboin, A., Sierra-Valdez, F. J., Chauhan, S. C., Cordero-Morales, J. F., & Vásquez, V. (2019) · Nature Communications · doi:10.1038/s41467-019-09055-7 · Cited by 266
Effects of Icosapent Ethyl on Total Ischemic Events
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.02.032 · Cited by 259
Metadata
- Authors
- Mason, R. P., Jacob, R. F., Shrivastava, S., Sherratt, S. C. R., & Chattopadhyay, A.
- Affiliations
- Brigham and Women's Hospital (US)
- Centre for Cellular and Molecular Biology (IN)
- Corresponding author
- Mason, R. Preston
- Venue
- Biochimica et Biophysica Acta (BBA) - Biomembranes
- Publisher
- Elsevier BV
- Published
- 2016-12
- Volume
- 1858
- Issue
- 12
- Pages
- 3131-3140
- ISSN
- 0005-2736 (ISSN-L)
- OpenAlex
- W2527894800
- Cited by
- 179
- References
- 76
- Citations by year
- 2026: 12 · 2025: 10 · 2024: 25 · 2023: 22 · 2022: 26 · 2021: 27 · 2020: 23 · 2019: 17 · 2018: 8 · 2017: 8
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Biochimica et Biophysica Acta (BBA) - Biomembranes (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Amarin Pharma
- Bangladesh Council of Scientific and Industrial Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Lipid Membrane Structure and Behavior
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- eicosapentaenoic acid, docosahexaenoic acid, omega-3 fatty acids, membrane fluidity, atherosclerosis, model membranes, cholesterol/phospholipid ratio, lipid peroxidation, long-chain fatty acids, glycyrrhizin, arachidonic acid, alpha-linolenic acid, lipid dynamics
- MeSH terms
- Cholesterol, Docosahexaenoic Acids, Dose-Response Relationship, Drug, Humans, Lipid Bilayers, Membrane Fluidity, Eicosapentaenoic Acid, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
